Related Experiment Video
Updated: Jun 20, 2026

06:45
Automated Joint Space Detection Improves Bone Segmentation Accuracy
Published on: November 28, 2025
Assessing single joints in arthritis clinical trials
Helen I Keen1, Clifton O Bingham, Laurence A Bradley
1School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. H.I.Keen@leeds.ac.uk
The Journal of Rheumatology
|September 10, 2009
Summary
Developing validated outcome measures for single joint therapies is crucial. This research reviews current methods for knee arthritis, focusing on the OMERACT filter to ensure reliable patient and imaging assessments.
Area of Science:
- Rheumatology
- Clinical Trials
- Medical Imaging
Background:
- Validated outcome measures are essential for evaluating single joint therapies.
- A task force established in 2004 assesses measures using the Outcome Measures in Rheumatology (OMERACT) filter (truth, discrimination, feasibility).
- This report details proceedings from the OMERACT 9 meeting concerning single joint assessment.
Purpose of the Study:
- To review and assess established and novel outcome measures for single joint assessment, particularly for knee arthritis.
- To evaluate imaging modalities for knee joints against the OMERACT filter criteria.
- To identify challenges and provide an evidence base for establishing core outcome domains in future therapeutic studies.
Main Methods:
- Updated literature review of knee joint imaging modalities.
- Examination of patient-reported, clinical examination, and imaging outcomes in knee arthritis therapeutic studies.
- Discussion of challenges in defining appropriate outcome domains for various conditions and interventions.
Main Results:
- An updated literature review assessed knee imaging modalities for their adherence to the OMERACT filter.
- Studies examining patient-reported, clinical, and imaging outcomes in knee arthritis were reported.
- Discussions highlighted ongoing challenges in domain selection for diverse conditions and therapies.
Conclusions:
- The ongoing work of the Special Interest Group (SIG) provides an evidence base for developing a core domain set for single joint outcome assessment.
- Addressing challenges in domain selection is critical for evaluating a range of conditions and therapeutic interventions.
- This evidence base will support the incorporation of standardized outcomes in future single joint therapeutic studies.

